Advocate Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Advocate Group's ABBV Position: Q3 2026 in Review
Advocate Group reduced its AbbVie (ABBV) stake by 9.5% in Q3 2026, selling an estimated $1.83M and leaving 67,923 shares worth $17.8M. The position accounts for 2.75% of the portfolio, ranked #3.
Advocate Group first reported a position in ABBV in Q2 2022 and has held it in 18 quarters since. The position peaked at $19M in Q3 2025. 2,036 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Advocate Group held 67,923 shares of AbbVie worth $17.8M as of Q3 2026.
- Advocate Group sold 7,144 AbbVie shares in Q3 2026, an estimated $1.83M.
- AbbVie made up 2.75% of Advocate Group's portfolio in Q3 2026, its #3 holding.
- Advocate Group first reported a position in AbbVie in Q2 2022 and has held it in 18 quarters since.
- Advocate Group's AbbVie position peaked at $19M in Q3 2025.
- 2,036 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Advocate Group's 13F filing for Q3 2026, filed 19 Oct 2026.